Guibel Perera, M.D.
NPI 1003928425ActiveIndividual· Internal Medicine, Nephrology· Miami, FL
Internal Medicine, Nephrology (M.D.) in Miami, Florida, licensed in PR, with an NPI issued in August 2006. Their prescriptions cost Medicare Part D more than their services did: $377,265 for 1,685 claims, against $54,655 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 6 companies reporting payments in 2025, $408.28 in all, mostly food and beverage.
Overview
| NPI | 1003928425 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Aug 31, 2006 |
| Last updated in NPPES | Feb 1, 2013 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Nephrology Primary | 207RN0300X | 15682 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Internal Medicine (FL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 59 |
|---|---|
| Services billed | 280 across 4 procedure codes |
| Paid by Medicare | $54,655 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,685 · 2,426 30-day fills |
|---|---|
| Patients | 245 |
| Total drug cost | $377,265 |
| Generic share | 70% of claims |
Education and affiliations
| Graduation year | 1995 |
|---|---|
| Medicare specialty | Internal Medicine |
| Secondary specialties | Nephrology |
Other facilities
- Davita Kendall Kidney CenterDialysis facility · Miami, FL
- Davita Tamiami DialysisDialysis facility · Miami, FL
Industry payments (Open Payments)
- 2025$408.28 · 18 payments from 6 companies
- 2024$770.03 · 21 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $133.76 | 6 |
| Calliditas Therapeutics US Inc. | $111.38 | 5 |
| Bayer Healthcare Pharmaceuticals Inc. | $82.40 | 3 |
| Ardelyx, Inc. | $42.86 | 2 |
| Otsuka America Pharmaceutical, Inc. | $23.66 | 1 |
What the 2025 payments were for
- Food and Beverage$388.06 · 17 payments
- Education$20.22 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Nephrology providers in Miami
- 1235459686
- 1578830840
- 1861418766
- 1730493677
- 1003082876
- 1366893232
- 1831031665
- 1346559176
- 1376321158
- 1316295447
- 1164441713
- 1932814381